Moreadith Randall
SEC insider (Form 3/4/5 filer). CIK 0001301120. Chief Scientific Officer at Serina Therapeutics, Inc. (SER). 85 reported Form 4/5 transactions since Sep 2024; latest on May 21, 2026. Located in HUNTSVILLE, AL.
Companies Moreadith Randall has filed insider reports for
- Serina Therapeutics, Inc. (SER): Officer, Chief Scientific Officer
Moreadith Randall
CIK: 0001301120
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Serina Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (85 total)
- May 21, 2026SER
Serina Therapeutics, Inc.
AwardDirectStock Option (right to buy)
85.6K shares- - Mar 23, 2026SER
Serina Therapeutics, Inc.
ExerciseDirect6.5K shares at avg. $0.06$390 - Mar 23, 2026SER
Serina Therapeutics, Inc.
SaleDirect6.5K shares at avg. $2.86$19K - Mar 19, 2026SER
Serina Therapeutics, Inc.
SaleDirect39K shares at avg. $2.50$98K - Mar 19, 2026SER
Serina Therapeutics, Inc.
ExerciseDirect39K shares at avg. $0.06$2K - Feb 3, 2026SER
Serina Therapeutics, Inc.
AwardDirectStock Option (right to buy)
69K shares- - Feb 2, 2026SER
Serina Therapeutics, Inc.
SaleDirect6.5K shares at avg. $3.03$20K - Feb 2, 2026SER
Serina Therapeutics, Inc.
ExerciseDirect6.5K shares at avg. $0.06$390 - Jan 28, 2026SER
Serina Therapeutics, Inc.
ExerciseDirect6.5K shares at avg. $0.06$390 - Jan 28, 2026SER
Serina Therapeutics, Inc.
SaleDirect6.5K shares at avg. $3.57$23K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 21, 2026 | SER Serina Therapeutics, Inc. | Award Stock Option (right to buy) | 85,558 | - | - | Direct |
| Mar 23, 2026 | SER Serina Therapeutics, Inc. | Exercise | 6,500 | $0.06 | $390 | Direct |
| Mar 23, 2026 | SER Serina Therapeutics, Inc. | Sale | 6,500 | $2.86 | $18,568 | Direct |
| Mar 19, 2026 | SER Serina Therapeutics, Inc. | Sale | 39,000 | $2.50 | $97,500 | Direct |
| Mar 19, 2026 | SER Serina Therapeutics, Inc. | Exercise | 39,000 | $0.06 | $2,340 | Direct |
| Feb 3, 2026 | SER Serina Therapeutics, Inc. | Award Stock Option (right to buy) | 69,000 | - | - | Direct |
| Feb 2, 2026 | SER Serina Therapeutics, Inc. | Sale | 6,500 | $3.03 | $19,680 | Direct |
| Feb 2, 2026 | SER Serina Therapeutics, Inc. | Exercise | 6,500 | $0.06 | $390 | Direct |
| Jan 28, 2026 | SER Serina Therapeutics, Inc. | Exercise | 6,500 | $0.06 | $390 | Direct |
| Jan 28, 2026 | SER Serina Therapeutics, Inc. | Sale | 6,500 | $3.57 | $23,186 | Direct |
1-10 of 85 transactions